Adverse Events and Oncotargeted Kinase Inhibitors (Hardcover). Este artículo no está disponible.
Idioma: inglés
Editorial: Elsevier Science Publishing Co Inc, San Diego, 2017
- Tapa dura
- Nuevo

Librería: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Vendedor de 5 estrellas
Vendedor de IberLibro desde 22 de junio de 2007
No disponible
Tapa dura
Condición: Nuevo
EUR 390,56
Descripción del artículo del vendedor
Hardcover. Adverse Events and Oncotargeted Kinase Inhibitors Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
N° de ref. del artículo 9780128094006
- Título
- Adverse Events and Oncotargeted Kinase Inhibitors (Hardcover)
- Autor
- Giuseppe Tridente
- Editorial
- Elsevier Science Publishing Co Inc, San Diego
- Año de publicación
- 2017
- Estado
- new
- Encuadernación
- Hardcover
- Idioma
- inglés
- ISBN 10
- 0128094001
- ISBN 13
- 9780128094006
Adverse Events and Oncotargeted Kinase Inhibitors gathers and evaluates data on adverse events associated with tyrosine kinase inhibitors (TKIs), a powerful anti-tumor drug class that has recently been introduced for human therapy. This book compiles a comprehensive safety profile of each TKI from experiences in official therapeutic indications, also exploring off-label exploratory investigations and postmarketing pharmaceutical surveillance databases. A brief history of each drug’s development and submission is provided, along with a more detailed analysis of the mechanism(s) of action involved in therapeutic activity or related to the insurgence of specific adverse events. Early chapters focus on general characteristics of TKIs, typology, and classification of adverse events, while the final chapters analyze TKIs as AE inducers and classes of AEs by system or organ involvement. This comprehensive resource compiles and critically reviews all of the relevant safety data for this class of drugs, with the goal of improving the understanding of pathogenesis and facilitating the prevention, monitoring, and management of these adverse events.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Professor Emeritus of Immunology and Pathology
School of Medicine and Surgery
Coordinator of the Teachers’ Committee for the Master in Translational Biomedicine
Universita degli Studi di Verona, Italy
“Acerca de” puede pertenecer a otra edición de este título.